Arizona Innovation Challenge winner, Beacon Biomedical Inc. is a medical diagnostic device company on a mission…to save as many lives as possible by providing easy, accurate and affordable blood tests for earlier cancer detection.
Dr. Marvin J. Slepian and James Wyant join those who have impacted quality of life, economic development and the welfare of society.Continue reading
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational radiosensitizer for glioblastoma multiforme.Continue reading
Beacon Biomedical, Inc., a privately held company focused on developing patient friendly cancer screening announced that it received an investment from Hyalescent Ventures.Continue reading
Accelerate Diagnostics, Inc. announced positive findings from a multicenter pilot study to evaluate external performance of its ID/AST System and Blood Culture Assay Kit. Based on the results of the study, the company also announced the initiation of its clinical trial for submission to the U.S. Food and Drug Administration.Continue reading
WASHINGTON, D.C. – Dec. 1, 2015 – Today, Congresswoman Kyrsten Sinema (AZ-09) and Congressman Mike Fitzpatrick (PA-08) introduced legislation reducing burdensome regulations on small and emerging businesses. The Fostering Innovation Act provides commonsense regulatory relief for companies on the cutting edge of scientific and medical research.